Aidigong Maternal & Child Health Limited is currently involved in ongoing litigation related to shareholder disputes and difficulties in accessing funds generated by its Shenzhen Aidigong operations. The company has been actively defending its interests through arbitration and various legal actions, particularly in response to disagreements over the exercise of shareholder rights and non-cooperation affecting the allocation of operational funds. These legal challenges have contributed to increased funding needs and have impacted the company's liquidity. As a result, trading in Aidigong's shares on the Hong Kong Stock Exchange has been suspended since February 21, 2025, and will remain halted until further notice. The company continues to monitor the situation and seek measures to improve its financial position.